Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
FSD Pharma Inc is a drug manufacturers—specialty & generic business based in the US. FSD Pharma shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. FSD Pharma employs 17 staff and has a market cap (total outstanding shares value) of USD$32.1 million.
|Latest market close||USD$1.44|
|52-week range||USD$2.15 - USD$10.9259|
|50-day moving average||USD$2.6731|
|200-day moving average||USD$3.3129|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.021|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||-2.70%|
|1 month (2020-11-06)||-5.26%|
|3 months (2020-09-04)||-47.64%|
|6 months (2020-06-05)||-73.53%|
|1 year (2019-12-05)||-69.95%|
|2 years (2018-12-04)||476.00%|
|3 years (2017-12-02)||N/A|
|5 years (2015-12-02)||N/A|
Valuing FSD Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FSD Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FSD Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$428,232.
The EBITDA is a measure of a FSD Pharma's overall financial performance and is widely used to measure a its profitability.
|Gross profit TTM||USD$-3,331,945|
|Return on assets TTM||-41.75%|
|Return on equity TTM||-93.65%|
|Market capitalisation||USD$32.1 million|
TTM: trailing 12 months
There are currently 75,456 FSD Pharma shares held short by investors – that's known as FSD Pharma's "short interest". This figure is 18.3% down from 92,313 last month.
There are a few different ways that this level of interest in shorting FSD Pharma shares can be evaluated.
FSD Pharma's "short interest ratio" (SIR) is the quantity of FSD Pharma shares currently shorted divided by the average quantity of FSD Pharma shares traded daily (recently around 328069.56521739). FSD Pharma's SIR currently stands at 0.23. In other words for every 100,000 FSD Pharma shares traded daily on the market, roughly 230 shares are currently held short.
However FSD Pharma's short interest can also be evaluated against the total number of FSD Pharma shares, or, against the total number of tradable FSD Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case FSD Pharma's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 FSD Pharma shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable FSD Pharma shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against FSD Pharma.
Find out more about how you can short FSD Pharma stock.
We're not expecting FSD Pharma to pay a dividend over the next 12 months.
FSD Pharma's shares were split on a 1:201 basis on 16 October 2019. So if you had owned 201 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma shares – just the quantity. However, indirectly, the new 20000% higher share price could have impacted the market appetite for FSD Pharma shares which in turn could have impacted FSD Pharma's share price.
Over the last 12 months, FSD Pharma's shares have ranged in value from as little as $2.15 up to $10.9259. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma's is 0.5425. This would suggest that FSD Pharma's shares are less volatile than average (for this exchange).
FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Toronto, Canada.
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.